AI in your radiology department has been cleared and deployed. Is anyone watching what it does next?
That is the question at the heart of a new consensus paper from the European Society of Radiology, published in Insights into Imaging. Using a modified Delphi procedure involving 16 domain experts, the ESR has produced a set of recommendations on post-market surveillance (PMS) and post-market clinical follow-up (PMCF) for AI medical devices in imaging - and the picture it paints of where the field currently stands is not reassuring.